An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 020444
Company: GLAXOSMITHKLINE LLC

Products on NDA 020444

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
FLOLAN	EPOPROSTENOL SODIUM	EQ 0.5MG BASE/VIAL	INJECTABLE;INJECTION	Discontinued	None	Yes	No
FLOLAN	EPOPROSTENOL SODIUM	EQ 1.5MG BASE/VIAL	INJECTABLE;INJECTION	Discontinued	None	Yes	No

Approval Date(s) and History, Letters, Labels, Reviews for NDA 020444

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
09/20/1995	ORIG-1	Approval	Type 1 - New Molecular Entity	PRIORITY; Orphan	Review (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/020444Orig1s000rev.pdf

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
08/24/2021	SUPPL-25	Labeling-Package Insert, Labeling-Patient Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020444s025lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/020444Orig1s025ltr.pdf
12/12/2018	SUPPL-24	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020444s024lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/020444Orig1s024ltr.pdf
10/23/2018	SUPPL-23	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020444s023lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/020444Orig1s023ltr.pdf
05/14/2018	SUPPL-22	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020444s022lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/020444Orig1s022ltr.pdf
04/17/2015	SUPPL-21	Manufacturing (CMC)	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020444s021lbl.pdf
03/29/2011	SUPPL-18	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020444s018lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/020444s018ltr.pdf
03/12/2008	SUPPL-16	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/020444s016lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/020444s016ltr.pdf
09/20/2002	SUPPL-10	Manufacturing (CMC)		Label is not available on this site.
06/21/2002	SUPPL-9	Manufacturing (CMC)		Label is not available on this site.
06/21/2002	SUPPL-8	Manufacturing (CMC)-Packaging		Label is not available on this site.
04/05/2002	SUPPL-7	Manufacturing (CMC)		Label is not available on this site.
01/17/2002	SUPPL-6	Manufacturing (CMC)		Label is not available on this site.
09/21/2000	SUPPL-5	Labeling		Label is not available on this site.
11/02/1999	SUPPL-4	Labeling		Label is not available on this site.
04/14/2000	SUPPL-3	Efficacy-New Indication	Label (PDF) Letter (PDF) Review		https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/20444S03LBL.PDF https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2000/20444S03LTR.PDF https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/20-444S003_Flolan.html
11/21/1997	SUPPL-2	Manufacturing (CMC)		Label is not available on this site.
03/18/1996	SUPPL-1	Labeling		Label is not available on this site.

Labels for NDA 020444

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
08/24/2021	SUPPL-25	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020444s025lbl.pdf
08/24/2021	SUPPL-25	Labeling-Patient Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020444s025lbl.pdf
12/12/2018	SUPPL-24	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020444s024lbl.pdf
10/23/2018	SUPPL-23	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020444s023lbl.pdf
05/14/2018	SUPPL-22	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020444s022lbl.pdf
04/17/2015	SUPPL-21	Manufacturing (CMC)	Label (PDF)	This supplement type does not usually require new labeling.	https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020444s021lbl.pdf
03/29/2011	SUPPL-18	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020444s018lbl.pdf
03/12/2008	SUPPL-16	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/020444s016lbl.pdf
04/14/2000	SUPPL-3	Efficacy-New Indication	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/20444S03LBL.PDF

Top